NANecmi Arslan

Necmi Arslan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Necmi Arslan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Selda Kargin Kaytez

    Department of Otorhinolaryngology-Head and Neck Surgery, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey

    3 shared publications
  • Hatice Celik

    Department of Otorhinolaryngology-Head and Neck Surgery, Ministry of Health, Ankara Training and Research Hospital

    2 shared publications
  • Nihat Yumuşak

    Department of Pathology, Harran University, Faculty of Veterinary Medicine

    2 shared publications
  • Özlem Akkoca

    Department of Otorhinolaryngology-Head and Neck Surgery, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey

    2 shared publications
  • Ahmet Dönder

    Department of Biochemistry, Faculty of Medicine, Dicle University, 21280 Diyarbakir, Turkey

    1 shared publication
  • Ahmet Yilmaz

    From the Department of Family Medicine (Yılmaz), School of Medicine, Dicle University, Diyarbakir, Department of Molecular Biology and Genetics (Kaymaz), Faculty of Arts and Sciences, Nevşehir, Hacı Bektaş Veli University, Nevşehir, Department of Family Medicine (Yakar, Gömleksiz, Önalan, Gürsu), Department of Internal Medicine (Önalan), School of Medicine, Firat University, Elazig, Turkey

    1 shared publication

Latest Publications

  • Pre- and post-induction probiotic administration in experimental otitis media with effusion: effects on effusion resolution and inflammation

    by Coşkun Ozdemir, Hatice Celik, Selda Kargin Kaytez, Nihat Yumusak, Onur Ercelik, Necmi Arslan

    Otitis Media with Effusion (OME) is defined as fluid accumulation in the middle ear without acute infection [1,2]. OME is prevalent in children, affecting over 50% of those younger than 1 year and ...

  • Open Access

    DENTAL GİRİŞİM SONRASINDA STREPTOCOCCUS ANGINOSUS’A BAĞLI GELİŞEN DERİN BOYUN ENFEKSİYONU

    by Berke Kurumanastırlı, Selda Kargın Kaytez, Serap Yağcı, Necmi Arslan

    Yerleşen yumuşak dokularda ortaya çıkan enfeksiyonlardır. Bu enfeksiyonlar, klinik olarak lenfadenit ve selülit şeklinde kendini sınırlayabileceği gibi gangren ve sepsis gibi hayatı tehdit edici enfeksiyonlara ilerleyebilmektedir. Bu enfeksiyonlarda, etiyolojik olarak en sık dental girişimler ve baş-boyun bölgesine olan travmalar sorumlu tutulmaktadır. Derin boyun enfeksiyonlarında yapılan mikrobiyolojik kültürlerde en sık izole edilen mikroorganizmalar stafilokok ve streptokoklardır. Bu olguda, Ankara Eğitim Araştırma Hastanesi Kulak Burun Boğaz Hastalıkları Servisi’nde dental girişim sonrası ortaya çıkan bir derin boyun enfeksiyonu vakası sunuldu. Hastadan intraoperatif olarak alınan yara aspirasyon kültüründe Streptococcus anginosus üremesi saptandı. Cerrahi müdahale ve antibiyotik tedavisi sonrası iyileşme gösteren hasta taburcu edildi. S. anginosus, normalde insan florasında bulunan ve immün sistemin baskılandığı durumlarda ciddi enfeksiyon etkeni olarak karşımıza çıkabilen bir bakteridir. Bu olguda tartışılan S. anginosus, derin boyun enfeksiyonuna sebep olabilen nadir mikroorganizmalardan biridir.

  • Open Access

    The Effect of Curcumin on the Prevention of Myringosclerosis in Rats

    by Özlem Akkoca, Selda Kargın Kaytez, Nihat Yumuşak, Akif Sinan Bilgen, Ali Kavuzlu, Ramazan Öcal, Hatice Çelik, Necmi Arslan

    The aim of this study was to investigate the preventative effect of oral curcumin (CMN) on myringosclerosis (MS) in an experimental rat model. The study included 21 female Wistar albino rats randomly separated into three groups. Group 1 was given no treatment (control group). In Group 2 and Group 3, the tympanic membrane (TM) was perforated using a sterile ear pick. The rats in Group 3 were administered oral CMN 200 mg/kg/day. All rats were sacrificed after 16 days. Otomicroscopic and histopathologic examinations were performed on the tympanic membranes. Histopathologic examinations revealed that there were statistically significant differences between Group 2 and Group 3 in terms of MS degrees (p<0.001) and mean thicknesses of TMs (p<0.001), but there were no differences between Group 1 and Group 3. In respect of MS detected by otomicroscopy, a statistically significant difference was determined between Groups 1 and 2 (p<0.001) and between Groups 2 and 3 (p<0.01), but there was no significant difference between Group 1 and Group 3 (p=0.575). Orally administered CMN can prevent myringosclerosis formation in experimentally induced myringotomies.


  • Open Access

    Effect of Folic Acid on Cisplatin-Induced Ototoxicity: A Functional and Morphological Study

    by Necmi Arslan, Zeynep Kaptan, Mehmet Emin Çavuş, Çiğdem Sönmez, Ozan Gökdoğan, İlker Akyıldız, Hatice Karadaş, Talip Talha Tanyeli, Naciye Dilara Zeybek, Hakkı Uzunkulaoğlu

    OBJECTIVES: The aim of our study was to investigate the effects of folic acid on cisplatin-induced ototoxicity. MATERIALS and METHODS: Thirty Wistar albino rats were divided into five groups. Group I received intraperitoneal cisplatin (IP) 10 mg/kg/day and IP folic acid 10 mg/kg/day; Group II received IP cisplatin 10 mg/kg/day and IP physiological saline; Group III received IP cisplatin 10 mg/kg/day and intratympanic (IT) folic acid 0.15 mL/day; Group IV received IP cisplatin 10 mg/kg/day and IT physiological saline; and Group V received IT folic acid 0.15 mL/day. Before and after drug administration, plasma homocysteine, folic acid levels, and auditory brainstem evoked responses (ABR) were measured. The rats were then sacrificed, and the inner ears were processed for electron microscopy. RESULTS: The differences of ABR thresholds in Group I compared to Group II were significantly smaller at 4 kHz, 8 kHz, and 16 kHz, whereas they were smaller but not statistically significant at 12 kHz in ABR. The differences of ABR thresholds in Group III compared to Group IV were significantly smaller at 12 kHz, and smaller but not statistically significant at 4 kHz, 8 kHz, and 16 kHz. Cisplatin treatment resulted in the degeneration of the cells of the organ of Corti, stria vascularis, and spiral ganglion. The cells of the organ of Corti, stria vascularis, and spiral ganglion showed a partially preserved morphology in both Group I and Group III. CONCLUSION: Our study results suggests that folic acid is a potential agent in preventing cisplatin-induced ototoxicity. Cite this article as: Tanyeli TT, Karadaş H, Akyıldız İ, Gökdoğan O, Sönmez Ç, Çavuş ME, et al. Effect of Folic Acid on Cisplatin-Induced Ototoxicity: A Functional and Morphological Study. J Int Adv Otol 2019; 15(2): 237-46.


  • The Effects of Systemic Disease on the Benign Paroxismal Positional Vertigo Attacks

    by Özlem Akkoca, Arzu Tüzüner, Ceren Ersöz Ünlü, Emine Aydın, Necmi Arslan


  • Open Access

    Protective Effects of Caffeic Acid Phenethyl Ester on Fluoxetine-Induced Hepatotoxicity: An Experimental Study

    by Ahmet Yılmaz, Bilal Elbey, Ümit Can Yazgan, Ahmet Dönder, Necmi Arslan, Serkan Arslan, Ulaş Alabalık, Hamza Aslanhan

    Background. The aim of the study was to analyse the effect of caffeic acid phenethyl ester (CAPE) on fluoxetine-induced hepatotoxicity in rats.Materials and Methods. Group I served as control. Group II received CAPE intraperitoneally. Group III received fluoxetine per orally. Group IV received fluoxetine and CAPE. The total antioxidant capacity (TAC), total oxidant status (TOS), oxidative stress index (OSI), and liver enzymes including paraoxonase-1 (PON-1), aspartate transaminase, and alanine transaminase levels were measured. Liver tissues were processed histopathologically for evaluation of liver injury and to validate the serum enzyme levels.Results. An increase in TOS and OSI and a decrease in TAC and PON-1 levels in serum and liver tissues of Group III were observed compared to Groups I and II. After treatment with CAPE, the level of TOS and OSI decreased while TAC and PON-1 increased in serum and liver in Group IV. Histopathological examination of the liver revealed hepatic injury after fluoxetine treatment and reduction of injury with CAPE treatment.Conclusion. Our results suggested that CAPE treatment provided protection against fluoxetine toxicity. Following CAPE treatment with fluoxetine-induced hepatotoxicity, TOS and OSI levels decreased, whereas PON-1 and TAC increased in the serum and liver.